Working in partnership with our healthcare clients to deliver data-driven, disease-specific predictions, we can support targeted cost-effective outreach and engagement of patient populations and sub-populations at high risk for certain illnesses.
Today, we support our clients and partners with technology, solutions and services that maximize insights gained from existing data. We are moving medicine from reactive to proactive care. Machine learning-based applications will predict and help prevent disease on a more personal level, rather than merely reacting to symptoms. Providers and payers will be better positioned to care for their patients’ needs with the tools to delay or prevent the onset of life-threatening conditions. Ultimately, patients will benefit from timely and personalized treatment to improve outcomes and potentially prolong life.
Whether you’re a Healthcare Provider or a Life Science Organization, Payer or Clinical Laboratory, our solutions are being deployed with less time, technology, and investment than anyone expected.
EarlySign delivers healthcare clients big impact with a low-risk investment and small effort by you and your teams.
Our outcome-focused AlgoMarker™ software solutions find subtle, early signs of high-risk patient trajectories for high-burden diseases and chronic conditions. EarlySign's AlgoMarkers do this using existing lab results and ordinary EHR data already collected in the course of routine care.
Even the greatest algorithms are of little value unless they can quickly become actionable. We work closely with clients to understand their clinical workflows, enabling them to timely identify and intervene with at-risk patients to prevent or delay the onset of specific diseases.